scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...980199S |
P356 | DOI | 10.1371/JOURNAL.PONE.0080199 |
P932 | PMC publication ID | 3925076 |
P698 | PubMed publication ID | 24551028 |
P5875 | ResearchGate publication ID | 260254544 |
P50 | author | Gautam Sethi | Q50077635 |
Matheswaran Kandasamy | Q56870606 | ||
Edward G Rowan | Q57419075 | ||
P2093 | author name string | Vincent T K Chow | |
Ramar Perumal Samy | |||
David Becker | |||
Bradley G Stiles | |||
Ponnampalam Gopalakrishnakone | |||
Muthu K Shanmugam | |||
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue | Q27629631 | ||
The crystal structure of a novel, inactive, lysine 49 PLA2 from Agkistrodon acutus venom: an ultrahigh resolution, AB initio structure determination | Q27641698 | ||
Antimicrobial peptides of multicellular organisms | Q28131811 | ||
The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling | Q28139111 | ||
Antimicrobial and Protease Inhibitory Functions of the Human Cathelicidin (hCAP18/LL-37) Prosequence | Q28201013 | ||
Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease | Q28266421 | ||
Defensins: antimicrobial and cytotoxic peptides of mammalian cells | Q28268268 | ||
The expanding superfamily of phospholipase A(2) enzymes: classification and characterization | Q28609761 | ||
Regulation of wound healing by growth factors and cytokines | Q29615242 | ||
Wound healing--aiming for perfect skin regeneration | Q29616715 | ||
Antibiotic susceptibility testing by a standardized single disk method | Q29616771 | ||
Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. | Q30332571 | ||
Biochemical, pharmacological and structural characterization of a new PLA2 from Crotalus durissus terrificus (South American rattlesnake) venom | Q33227019 | ||
Myotoxin II from Bothrops asper (Terciopelo) venom is a lysine-49 phospholipase A2. | Q43798720 | ||
Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration | Q44043390 | ||
Contribution of crotoxin for the inhibitory effect of Crotalus durissus terrificus snake venom on macrophage function. | Q44462566 | ||
Structural, enzymatic and biological properties of new PLA(2) isoform from Crotalus durissus terrificus venom | Q44522226 | ||
An acidic phospholipase A₂ with antibacterial activity from Porthidium nasutum snake venom | Q46264142 | ||
Antimicrobial activity of myotoxic phospholipases A2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region | Q46498997 | ||
Fungicidal activity of a phospholipase-A2-derived synthetic peptide variant against Candida albicans | Q46676659 | ||
Permeabilization of E. coli K12 inner and outer membranes by bothropstoxin-I, A LYS49 phospholipase A2 from Bothrops jararacussu | Q46832761 | ||
Expression of genes encoding antimicrobial proteins and members of the toll-like receptor/nuclear factor-kappaB pathways in engineered human skin. | Q47444684 | ||
Wound age estimation by simultaneous detection of 9 cytokines in human dermal wounds with a multiplex bead-based immunoassay: an estimative method using outsourced examinations | Q47870102 | ||
Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom--synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region | Q47881529 | ||
Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). | Q52544493 | ||
Antibacterial activity of crotalid venoms against oral snake flora and other clinical bacteria. | Q54292593 | ||
In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus. | Q54365857 | ||
The action of various venoms on Escherichia coli. | Q54773532 | ||
Glycopeptide and daptomycin resistance in community-associated MRSA in the UK | Q61639667 | ||
Comparison of a relatively toxic phospholipase A2 from Naja nigricollis snake venom with that of a relatively non-toxic phospholipase A2 from Hemachatus haemachatus snake venom--II. Pharmacological properties in relationship to enzymatic activity | Q71259457 | ||
c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin | Q73291709 | ||
Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing | Q74329802 | ||
Localization of human beta-defensin-2 and human neutrophil peptides in superficial folliculitis | Q78815783 | ||
Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes | Q79797820 | ||
[The relationship between scarless wound healing and the expression of CD68 and CD3 in the immunocytes in fetal skin] | Q82112328 | ||
Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway | Q83170129 | ||
In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei | Q33247230 | ||
Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity | Q33552284 | ||
Evidence for a purifying selection acting on the β-lactamase locus in epidemic clones of methicillin-resistant Staphylococcus aureus | Q33874284 | ||
Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. | Q34124317 | ||
Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors | Q34198845 | ||
Aging and wound healing | Q34298460 | ||
Understanding the role of immune regulation in wound healing | Q34321358 | ||
The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. | Q34386752 | ||
Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures | Q34474542 | ||
Cathelicidins--a family of multifunctional antimicrobial peptides. | Q34534231 | ||
Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance | Q34737155 | ||
Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells | Q35098397 | ||
The myofibroblast in wound healing and fibrocontractive diseases | Q35170446 | ||
An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action | Q35690573 | ||
Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice | Q35788394 | ||
Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring | Q35843492 | ||
Vascular endothelial growth factor and angiogenesis | Q35985850 | ||
Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth | Q36561412 | ||
Novel therapies based on cationic antimicrobial peptides | Q36570155 | ||
Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections | Q36916071 | ||
Antibacterial actions of secreted phospholipases A2. Review | Q37051581 | ||
The phospholipase A2 homologues of snake venoms: biological activities and their possible adaptive roles | Q37581920 | ||
Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. | Q38302217 | ||
Snake venomics of the Central American rattlesnake Crotalus simus and the South American Crotalus durissus complex points to neurotoxicity as an adaptive paedomorphic trend along Crotalus dispersal in South America | Q38929637 | ||
Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice | Q39564473 | ||
Cationic hydrophobic peptides with antimicrobial activity | Q39657941 | ||
Identification and characterization of a phospholipase A2 from the venom of the Saw-scaled viper: Novel bactericidal and membrane damaging activities | Q39665629 | ||
Viper metalloproteinase (Agkistrodon halys pallas) with antimicrobial activity against multi-drug resistant human pathogens | Q40009207 | ||
Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity | Q40399225 | ||
Bactericidal and antiendotoxic properties of short cationic peptides derived from a snake venom Lys49 phospholipase A2. | Q40442273 | ||
Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells. | Q40547600 | ||
The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. | Q40590049 | ||
Measurement of invasion by gentamicin resistance | Q41502010 | ||
Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins | Q42001747 | ||
Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization | Q42518445 | ||
In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections | Q43141290 | ||
Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom | Q43616017 | ||
Effects of chemical modifications of crotoxin B, the phospholipase A(2) subunit of crotoxin from Crotalus durissus terrificus snake venom, on its enzymatic and pharmacological activities | Q43680853 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | snake venom | Q424200 |
eastern diamondback rattlesnake | Q744532 | ||
wound healing | Q1509074 | ||
P304 | page(s) | e80199 | |
P577 | publication date | 2014-02-14 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus) | |
P478 | volume | 9 |
Q89919373 | A microbiome and metabolomic signature of phases of cutaneous healing identified by profiling sequential acute wounds of human skin: An exploratory study |
Q98177913 | Acidic Phospholipase A2-Peptide Derivative Modulates Oxidative Status and Microstructural Reorganization of Scar Tissue after Cutaneous Injury |
Q89697972 | Antibacterial and Hemolytic Activity of Crotalus Triseriatus and Crotalus Ravus Venom |
Q52592947 | Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds. |
Q34507671 | Antimicrobial peptides and wound healing: biological and therapeutic considerations |
Q47368100 | Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis |
Q60936798 | Next-generation sequencing analysis reveals high bacterial diversity in wild venomous and non-venomous snakes from India |
Q28829884 | Symbiosis theory-directed green synthesis of silver nanoparticles and their application in infected wound healing |
Q39003770 | Synergistic antibacterial effect of co-administering adipose-derived mesenchymal stromal cells and Ophiophagus hannah L-amino acid oxidase in a mouse model of methicillin-resistant Staphylococcus aureus-infected wounds |
Q38401924 | Therapeutic utility of antibacterial peptides in wound healing |
Q35677777 | Topical application of Acheflan on rat skin injury accelerates wound healing: a histopathological, immunohistochemical and biochemical study |
Q98726494 | Venom peptides in association with standard drugs: a novel strategy for combating antibiotic resistance - an overview |
Search more.